Screening for CMV in pregnancy

     

The National Institute for Clinical Excellence (NICE) currently do not recommend routine antenatal screening for CMV. This because there is currently no way of preventing transmission of the virus to an unborn baby and no way to determine whether a baby will be born with problems.

A study in the US is testing whether CMV Immunoglobulin therapy may reduce the risk of transmission when given to pregnant women experiencing a primary CMV infection. This follows mixed results from previous studies of immunoglobulin therapy in Italy.  The US study is due to report in 2019.

In the meantime, CMV Action is working with researchers to try and secure funding for a pilot to test out how CMV screening in pregnancy could work within the NHS.

 

     

Our Stories

Joshua_newborn_CMV
When our youngest son was born in 2001, apart from a little jaundice he seemed 'normal'. It was only as time passed and developmental milestones were not reached, that concerns began. He... Read more
We noticed Ruby wasn't responding to sound when she was about 18 months old. My GP said she was fine and said I was a worrying first time mum. Without the support of our GP, we paid... Read more

Latest Events

Registered charity no: 1171773

Customize This